CAR T Companion Tool brings trusted information, a personal treatment wallet card, and a clinician quick-reference together in one place — so patients, caregivers, and care teams can navigate relapsed or refractory non-Hodgkin lymphoma with confidence.
Companion ToolWelcome back — here's your CAR T-cell roadmap.
For educational purposes only. The tool does not determine patient eligibility or replace consultation with a CAR T treatment center.
Stay informed. Stay empowered. Walk into every appointment prepared.
A diagnosis of non-Hodgkin lymphoma brings many questions. The Patient FAQ breaks down the disease, testing, treatment options, and what to expect from CAR T-cell therapy in clear, everyday language.
This patient has received CAR T-cell therapy for the treatment of
Non-Hodgkin lymphoma
Fill in your CAR T-cell therapy details once and keep a digital wallet card with you at all times — treating oncologist, infusion date, batch number, and emergency contacts, ready to print or share.
FDA-approved CAR T-cell therapies for relapsed or refractory NHL, referral contacts, and guidance on which patients to refer — sourced to the FDA, NCCN, and ASTCT so you can act with confidence.
For educational purposes only. The tool does not determine patient eligibility or replace consultation with a CAR T treatment center.
Provided by Integritas Communications · For educational purposes only
